STOCK TITAN

EDAP TMS SA (EDAP) CFO discloses stock and option holdings on Form 3 filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

EDAP TMS SA filed an initial ownership report showing that Chief Financial Officer Kenneth S. Mobeck beneficially owns 56,610 shares of common stock as of 01/01/2026, held directly. This amount includes restricted stock units granted under the company’s 2025 RSU (Free Share) Plan, where each RSU represents the right to receive one share of EDAP common stock with vesting stretching from the second anniversary of the June 20, 2025 grant date through June 20, 2028.

He also directly holds stock options covering 375,000 shares exercisable until 12/15/2032 at $11.68 per share, options on 100,000 shares expiring 01/18/2034 at $6.22 per share, and options on 165,000 shares expiring 06/20/2035 at $1.74 per share. The options vest in stages over several years based on specified schedules tied to each grant date.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Mobeck Kenneth S.

(Last) (First) (Middle)
4410 EL CAMINO REAL
SUITE 150

(Street)
LOS ALTOS, CA 94022

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2026
3. Issuer Name and Ticker or Trading Symbol
EDAP TMS SA [ EDAP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock(1) 56,610 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (2) 12/15/2032 Common Stock 375,000 $11.68(3) D
Stock Options (4) 01/18/2034 Common Stock 100,000 $6.22(5) D
Stock Options (6) 06/20/2035 Common Stock 165,000 $1.74(7) D
Explanation of Responses:
1. Includes restricted stock units ("RSUs") granted pursuant to the 2025 RSU (Free Share) Plan of the issuer on June 20, 2025. Each RSU represents the right to receive one share of EDAP common stock, four-sixths of which will vest on the second anniversary of the date of grant and the remaining two-sixths will vest in two installments on December 20, 2027 and on June 20, 2028, respectively.
2. The options, which were granted on December 15, 2022, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options.
3. The option exercise price reflected was converted from 9.94 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750.
4. The options, which were granted on January 18, 2024, became exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and became exercisable or will become exercisable on a monthly basis thereafter through the third anniversary of the date of grant with respect to the remaining options.
5. The option exercise price reflected was converted from 5.29 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750.
6. One-sixth of the options become exercisable on December 20, 2025, which is the six-month anniversary of the date of grant, and with respect to the remaining five-sixths of the options, one-thirtieth become exercisable at the end of each month following the six-month anniversary of the date of grant.
7. The option exercise price reflected was converted from 1.48 euros into U.S. dollars based on an exchange rate of EUR 1 to USD 1.1750.
/s/ Blandine Confort, as Attorney-in-Fact 01/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the EDAP (EDAP) Form 3 filing report for the CFO?

The Form 3 shows that Chief Financial Officer Kenneth S. Mobeck beneficially owns 56,610 shares of EDAP common stock and several stock option grants, all held directly.

How many EDAP TMS SA common shares does the CFO beneficially own?

He beneficially owns 56,610 shares of EDAP common stock, held directly, including shares underlying restricted stock units granted under the 2025 RSU (Free Share) Plan.

What stock options does the EDAP CFO hold according to the Form 3?

He holds options for 375,000 shares expiring 12/15/2032 at $11.68, 100,000 shares expiring 01/18/2034 at $6.22, and 165,000 shares expiring 06/20/2035 at $1.74 per share, all directly owned.

How do the EDAP CFO’s RSUs under the 2025 RSU Plan vest?

Under the 2025 RSU (Free Share) Plan, each RSU represents one EDAP share; four-sixths vest on the second anniversary of the June 20, 2025 grant, and the remaining two-sixths vest on December 20, 2027 and June 20, 2028.

What are the vesting terms for the EDAP options granted in December 2022?

Options granted on December 15, 2022 became exercisable for one-sixth of the grant six months after the grant date, then on a monthly basis through the third anniversary for the remaining options.

How do the January 2024 and June 2025 EDAP option grants vest for the CFO?

The January 18, 2024 options vest one-sixth at six months, then monthly through the third anniversary. The June 20, 2025 options vest one-sixth on December 20, 2025, with the remaining five-sixths vesting in monthly one-thirtieth installments thereafter.
Edap Tms

NASDAQ:EDAP

EDAP Rankings

EDAP Latest News

EDAP Latest SEC Filings

EDAP Stock Data

152.93M
37.39M
37.83%
0.44%
Medical Distribution
Healthcare
Link
France
Vaulx-en-Velin